WS #13383
Holding: newest synthesis is 98d 23h old
Pfizer beats and raises revenue guidance, but Merck cuts EPS guidance sharply and BioNTech slashes sales outlook, creating mixed sector signals.
Pharma/Biotech Divergence
Pfizer beats and raises revenue guidance, but Merck cuts EPS guidance sharply and BioNTech slashes sales outlook, creating mixed sector signals.